POXEL
Developing innovative metabolic treatments
- B2B
About POXEL
Clinical stage biopharmaceutical company developing treatments for NASH, rare disorders, and metabolic diseases with innovative drugs and partnerships for global growth
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Lyon, Auvergne-Rhône-Alpes, France
- Founded
- 2009
- Revenue
- €6.6MFY2024, publicly reported
- Website
- poxelpharma.com
- linkedin.com/company/poxel
POXEL at a glance
POXEL is a B2B company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, France.
POXEL was founded in 2009.
POXEL has 11–50 employees.
POXEL's revenue is €6.6M (FY2024, publicly reported).
Selling to companies like POXEL?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies